glp-1 and seizures Glucagon-like peptide 1 (GLP-1) 🔸 Should GLP-1 RAs be
Description
On average, user households spent 418 less than their non-user counterparts
Gallbladder disorders were reported in 2.6% of patients on semaglutide versus 1.2% on placebo more than double the rate
PMID: 3543057
Individuals Struggling With Appetite Control and Portion Regulation GLP-1 medications may be considered for individuals who experience persistent hunger, frequent snacking, or difficulty controlling portion sizes despite efforts to modify diet and eating habits
